五千年(敝帚自珍)

主题:选择坏蛋淘汰好人的国家还是离开的好 -- forger

共:💬119 🌺401 🌵18
全看分页树展 · 主题 跟帖
家园 印度的专利法有相关的条款中国新修订的专利法也有

只不过在印度好像尚无成功应用的案例而已.不过印度有以公众利益为由允许国内厂商仿制药品的案例:

After Roche’s successful stint at winning Pegasys’ patent in the opposition proceeding, it faced the first blow to its Patent Rights for Tarceva, an anti-cancer drug. Roche sued Cipla before Delhi High Court claiming that Cipla’s generic product Erlocip violates former’s Indian Patent IN196774 claiming “Erlotinib Hydrocloride”. The trial Judge held against Roche on the ground of “public interest”, rejecting Roche’s appeal to grant interim injunction restraining Cipla from selling generic version of Tarcev as Cipla’s drug costs about 1/3rd of Roche’s patented drug.

全看分页树展 · 主题 跟帖


有趣有益,互惠互利;开阔视野,博采众长。
虚拟的网络,真实的人。天南地北客,相逢皆朋友

Copyright © cchere 西西河